STOCK TITAN

TSHA (Nasdaq: TSHA) insider plans Rule 144 sale of 32,077 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

An affiliate of the issuer has filed a notice of proposed sale of 32,077 shares of common stock under Rule 144. The planned sale, with an aggregate market value of $163,271.93, is to be executed through Maxim Group LLC on or about 01/23/2026 on the Nasdaq exchange.

The 32,077 shares were acquired on 01/23/2026 via an RSU award from the issuer, with payment in the form of the reporting person’s continued employment and the award vesting and settling in stock on that date. The filing notes that there were 273,919,373 shares of this class of common stock outstanding.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does this Form 144 filing for TSHA relate to?

It relates to a proposed sale under Rule 144 of 32,077 shares of common stock of the issuer by or for the account of a person associated with the company.

How many TSHA shares are planned to be sold and at what value?

The notice covers a proposed sale of 32,077 common shares with an aggregate market value of $163,271.93, as stated in the filing.

When and where are the TSHA shares expected to be sold?

The approximate date of sale is listed as 01/23/2026, with trades to occur on the Nasdaq exchange through Maxim Group LLC.

How were the 32,077 TSHA shares being sold acquired?

The 32,077 shares were acquired on 01/23/2026 as an RSU award from the issuer, described as a vested grant settled in stock in consideration for the reporting person’s continued service as an employee.

How many TSHA common shares were outstanding according to this notice?

The filing states that 273,919,373 shares of the issuer’s common stock were outstanding for this class at the time referenced.

Who is the broker handling this proposed TSHA share sale?

The proposed sale is to be handled by Maxim Group LLC, located at 300 Park Avenue, 16th Floor, New York, NY 10022.
Taysha Gene Therapies, Inc.

NASDAQ:TSHA

TSHA Rankings

TSHA Latest News

TSHA Latest SEC Filings

TSHA Stock Data

1.39B
242.89M
11.15%
94.76%
14.95%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
DALLAS